Vijaya Diagno Peer Comparison
NSE: VIJAYA | BSE: 543350
₹1,572.30
As on 20-Nov-2026IST
Market cap
₹16,186 Cr
Revenue (TTM)
₹911 Cr
P/E Ratio
79.5
P/B Ratio
15.3
Div. Yield
0.1 %
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
16,186 | 39,829 | 33,680 | 33,483 | 11,742 |
Revenue (₹ Cr) |
911 | 5,053 | 3,034 | 4,596 | 1,778 |
Net Profit (₹ Cr) |
203.68 | 613.08 | 588.10 | 193.80 | 225.41 |
Net Margin (%) |
21.86 | 11.89 | 18.68 | 4.17 | 12.46 |
RoE (%) |
20.22 | 15.63 | 23.05 | 6.86 | 14.63 |
Price to Earnings |
79.47 | 64.41 | 57.72 | 157.64 | 52.35 |
Price-To-Book |
15.31 | 9.21 | 12.27 | 8.52 | 7.15 |
Income Statement (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Operating Revenue
|
910.96 | 5,053.19 | 3,034.10 | 4,596.20 | 1,777.63 |
|
Total Income
|
931.94 | 5,157.49 | 3,148.70 | 4,646.10 | 1,808.40 |
|
Total Expenditure
|
518.10 | 3,935.28 | 2,140.30 | 3,707.10 | 1,329.55 |
|
EBITDA
|
392.86 | 1,117.91 | 893.80 | 889.10 | 448.08 |
|
Depreciation
|
100.69 | 267.48 | 178.00 | 385.20 | 135.92 |
|
EBIT
|
292.17 | 850.43 | 715.80 | 503.90 | 312.16 |
|
Interest
|
40.30 | 102.98 | 26.60 | 273.80 | 26.83 |
|
Other Income
|
20.98 | 104.30 | 114.60 | 49.90 | 30.77 |
|
Exceptional Items
|
0.00 | -36.60 | -30.10 | 2.30 | -8.99 |
|
Profit before Tax
|
272.85 | 815.15 | 773.70 | 282.30 | 307.11 |
|
Provision for Tax
|
69.17 | 202.07 | 185.60 | 88.50 | 81.70 |
|
Profit after Tax
|
203.68 | 613.08 | 588.10 | 193.80 | 225.41 |
Liabilities (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,057.33 | 4,323.39 | 2,744.50 | 3,931.80 | 1,641.54 |
|
Minority Interest
|
0.00 | 5.33 | -4.50 | 15.40 | -1.12 |
|
Non-Current Liabilities
|
515.16 | 1,495.04 | 190.40 | 3,247.20 | 316.09 |
|
Current Liabilities
|
160.86 | 768.03 | 487.70 | 1,412.60 | 371.40 |
|
Total Liabilities
|
1,507.05 | 5,905.00 | 3,139.97 | 7,690.70 | 2,524.76 |
Assets (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
773.26 | 3,286.77 | 1,196.40 | 6,040.80 | 1,414.47 |
|
Current Assets
|
449.80 | 2,088.60 | 1,883.10 | 1,476.90 | 636.38 |
|
Total Assets
|
1,507.05 | 5,905.00 | 3,139.97 | 7,690.70 | 2,524.76 |
|
Total Debt*
|
0.00 | 631.08 | 0.00 | 3,244.00 | 18.73 |
|
Net Current Assets
|
288.94 | 1,320.56 | 1,395.40 | 64.30 | 264.99 |
|
Contingent Liabilities
|
0.13 | 100.01 | 16.76 | 81.10 | 10.08 |
Cashflow (₹ Cr)
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
270.59 | 714.39 | 635.61 | 510.80 | 350.70 |
|
Cash Flow from Investing Activities
|
-174.22 | -1,089.11 | -421.86 | -1,451.70 | -223.13 |
|
Cash from Financing Activities
|
-69.49 | 271.85 | -263.57 | 940.30 | -115.29 |
|
Net Cash Inflow / Outflow
|
26.88 | -102.87 | -49.83 | -0.60 | 12.28 |
Ratios
Profitability Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
ROCE (%)
|
30.28 | 19.38 | 29.56 | 11.51 | 20.03 |
|
ROE (%)
|
20.22 | 15.63 | 23.05 | 6.86 | 14.63 |
|
ROA (%)
|
13.04 | 10.20 | 18.33 | 2.49 | 10.40 |
|
EBIT Margin (%)
|
32.07 | 16.83 | 23.59 | 10.96 | 17.56 |
|
Net Margin (%)
|
21.86 | 11.89 | 18.68 | 4.17 | 12.46 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
24.47 | 26.18 | 16.71 | 35.12 | 19.84 |
|
EBIT Growth (%)
|
38.42 | 16.83 | 20.83 | -10.81 | 46.75 |
|
Net Profit Growth (%)
|
33.97 | 9.16 | 8.95 | -45.50 | 41.91 |
|
EPS Growth (%)
|
33.02 | 13.12 | -43.47 | -36.93 | -40.95 |
|
Book Value Growth (%)
|
21.86 | 16.51 | 15.41 | 5.13 | 13.54 |
Valuation Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Price / Earnings
|
79.38 | 61.51 | 55.57 | 154.21 | 31.31 |
|
Price / Book Value
|
15.31 | 9.21 | 12.27 | 8.52 | 7.15 |
|
Dividend Yield (%)
|
0.13 | 0.03 | 1.02 | 0.00 | 0.88 |
|
EV/EBITDA
|
40.48 | 35.18 | 36.19 | 41.21 | 25.79 |
|
Market Cap (₹ Cr)
|
8,864.05 | 25,841.07 | 22,015.15 | 24,901.98 | 8,992.90 |
Solvency Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.15 | 0.00 | 0.49 | 0.00 |
|
Short term debt to equity ratio
|
-- | -- | -- | 0.15 | 0.01 |
|
Current Ratio
|
2.80 | 2.72 | 3.86 | 1.05 | 1.71 |
|
Quick Ratio
|
2.74 | 2.60 | 3.75 | 0.96 | 1.58 |
|
Interest Coverage
|
7.77 | 8.92 | 30.09 | 2.03 | 12.45 |
Operating Efficiency Ratios
| Vijaya Diagno | Global Health | Dr. Lal Pathlabs | Krishna Institute | Metropolis Health | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
1.97 | 10.34 | 4.66 | 15.03 | 10.36 |
|
Asset Turnover
|
0.58 | 0.84 | 0.95 | 0.59 | 0.82 |
|
Receivable days
|
7.98 | 29.09 | 13.13 | 44.38 | 35.29 |
|
Inventory Days
|
2.20 | 6.05 | 5.28 | 7.52 | 10.35 |
|
Payable days
|
136.27 | 80.04 | 118.67 | 133.54 | 143.56 |
|
Cash Conversion Cycle
|
-126.08 | -44.90 | -100.26 | -81.64 | -97.92 |